Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
158.61
-1.31 (-0.82%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Belite Bio Employees
Belite Bio had 41 employees as of December 31, 2025. The number of employees increased by 16 or 64.00% compared to the previous year.
Employees
41
Change (1Y)
16
Growth (1Y)
64.00%
Revenue / Employee
n/a
Profits / Employee
-$2,201,756
Market Cap
6.24B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 41 | 16 | 64.00% |
| Dec 31, 2024 | 25 | 5 | 25.00% |
| Dec 31, 2023 | 20 | 4 | 25.00% |
| Dec 31, 2022 | 16 | 4 | 33.33% |
| Dec 31, 2021 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Mirum Pharmaceuticals | 418 |
| Xenon Pharmaceuticals | 370 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| CG Oncology | 142 |
| Definium Therapeutics | 106 |
| Erasca | 103 |
BLTE News
- 11 days ago - Belite Bio Transcript: H.C. Wainwright 6th Annual Ophthalmology Virtual Conference - Transcripts
- 12 days ago - Belite Bio Slides: Study result presentation - Filings
- 13 days ago - Belite Bio Announces Oral Presentation at the ASRS Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1 - GlobeNewsWire
- 18 days ago - Belite Bio to Participate in the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference - GlobeNewsWire
- 24 days ago - Belite Bio Transcript: Piper Sandler Virtual Ophthalmology Day - Transcripts
- 27 days ago - Belite Bio to Participate in the Piper Sandler Virtual Ophthalmology Investor Symposium - GlobeNewsWire
- 27 days ago - Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences - GlobeNewsWire
- 6 weeks ago - Belite Bio completes rolling submission of NDA to U.S. FDA for tinlarebant - TheFly